BioSpace News Archive

Genetown

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Aug 31, 2021

Spero Therapeutics, Inc. announced that on August 31, 2021, the Compensation Committee of Spero’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 98,300 shares of its common stock to 7 new employees under the Spero Therapeutics, Inc.

August 31, 2021
·
2 min read
Pharm Country

Certara to Participate in Upcoming Investor Conferences

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in a fireside chat at the following virtual investor conferences:

August 31, 2021
·
1 min read
Business

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial ResultsConference Call Scheduled for September 9, 2021 at 11:00 am EASTERN

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2021 on Thursday, September 9, 2021.

August 31, 2021
·
2 min read
Cardax Refocuses on ZanthoSyn® Consumer Health Business

Cardax, Inc., announced today that it is refocusing its business strategy on its astaxanthin dietary supplement ZanthoSyn® for consumer health.

August 31, 2021
·
5 min read
Biotech Beach

HSS Study Seeks to Optimize Patient Selection for Major Foot Surgery

A new study by researchers at Hospital for Special Surgery in New York City could help orthopedic surgeons better identify which patients will benefit most from surgery to correct debilitating age-related deterioration of their foot arches.

August 31, 2021
·
5 min read
European Stroke Organisation Conference (ESOC) 2021: Non-traditional risk factors for heart attack and stroke rising more steeply in women, major study reveals

Work stress, sleep disorders, and fatigue, regarded as non-traditional risk factors for heart attack and stroke, are rising more steeply amongst women than men, according to a new study presented today at the European Stroke Organisation (ESO) Conference.

August 31, 2021
·
2 min read
SynForU(TM)-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women

The first clinical study which has been published in the Journal of Applied Microbiology documents that SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences of vaginal candidiasis (VC) in pregnant women.

August 31, 2021
·
3 min read
ETERN Therapeutics Announces Completion of Series B Financing to Advance the Protein Liquid-Liquid Phase Separation Technology Platform and Accelerate the Development of Novel Drugs to Target “Undruggable” Proteins

ETERN Therapeutics, a clinical-stage biotech company focusing on developing novel technologies to target “undruggable” proteins, announced the completion of a Series B financing round.

August 31, 2021
·
4 min read
Business

Lung Therapeutics, Inc. Strengthens Board of Directors with Appointment of Biopharmaceutical Veteran William C. Fairey

Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary diseases and conditions, announced the appointment of William C. Fairey to the Board of Directors.

August 31, 2021
·
3 min read
BioCapital

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2021

I-Mab to host conference calls and webcasts on August 31, 2021. A Mandarin session conference call will be held at 7:00 a.m. ET, and an English session conference call will be held at 8:00 a.m. ET.

August 31, 2021
·
41 min read